102 related articles for article (PubMed ID: 7504339)
1. Validation and quality assurance program for monitoring tacrolimus (FK 506) concentrations in plasma and whole blood.
D'Ambrosio R; Girzaitis N; Jusko WJ
Ther Drug Monit; 1993 Oct; 15(5):414-26. PubMed ID: 7504339
[TBL] [Abstract][Full Text] [Related]
2. Monitoring FK 506 concentrations in plasma and whole blood.
Jusko WJ; D'Ambrosio R
Transplant Proc; 1991 Dec; 23(6):2732-5. PubMed ID: 1721260
[TBL] [Abstract][Full Text] [Related]
3. Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring.
Jusko WJ
Ther Drug Monit; 1995 Dec; 17(6):596-601. PubMed ID: 8588227
[TBL] [Abstract][Full Text] [Related]
4. Multicenter comparison of tacrolimus (FK 506) whole blood concentrations as measured by the Abbott IMX analyzer and enzyme immunoassay with methylene chloride extraction.
D'Ambrosio R; Girzaitis N; Jusko WJ
Ther Drug Monit; 1994 Jun; 16(3):287-92. PubMed ID: 7521979
[TBL] [Abstract][Full Text] [Related]
5. Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression.
Winkler M; Ringe B; Baumann J; Loss M; Wonigeit K; Pichlmayr R
Clin Chem; 1994 Dec; 40(12):2247-53. PubMed ID: 7527306
[TBL] [Abstract][Full Text] [Related]
6. Radioreceptor assay for quantifying FK-506 immunosuppressant in whole blood.
Murthy JN; Chen Y; Warty VS; Venkataramanan R; Donnelly JG; Zeevi A; Soldin SJ
Clin Chem; 1992 Jul; 38(7):1307-10. PubMed ID: 1377995
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
Marubashi S; Nagano H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Monden M; Doki Y; Mori M
J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance procedure for monitoring tacrolimus (FK506) concentrations in whole blood by IMx assay.
Alak AM; Lizak PP
Ther Drug Monit; 1996 Jun; 18(3):267-72. PubMed ID: 8738766
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different assays for the quantitation of FK 506 levels in blood or plasma.
Winkler M; Christians U; Stoll K; Baumann J; Pichlmayr R
Ther Drug Monit; 1994 Jun; 16(3):281-6. PubMed ID: 7521978
[TBL] [Abstract][Full Text] [Related]
10. FK 506: monitoring in plasma or in whole blood?
Beysens AJ; Wijnen RM; Beuman GH; van der Heyden J; Kootstra G; van As H
Transplant Proc; 1991 Dec; 23(6):2745-7. PubMed ID: 1721263
[No Abstract] [Full Text] [Related]
11. Multi-center analytical evaluation of a novel automated tacrolimus immunoassay.
Shipkova M; Vogeser M; Ramos PA; Verstraete AG; Orth M; Schneider C; Wallemacq P
Clin Biochem; 2014 Aug; 47(12):1069-77. PubMed ID: 24721684
[TBL] [Abstract][Full Text] [Related]
12. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
13. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
[TBL] [Abstract][Full Text] [Related]
14. Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay.
Tolou-Ghamari Z; Palizban AA; Michael Tredger J
Drugs R D; 2004; 5(1):17-22. PubMed ID: 14725486
[No Abstract] [Full Text] [Related]
15. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
Hermida J; Tutor JC
Clin Lab; 2003; 49(9-10):471-4. PubMed ID: 14572203
[TBL] [Abstract][Full Text] [Related]
16. Stability of FK 506 in whole blood samples.
Freeman DJ; Stawecki M; Howson B
Ther Drug Monit; 1995 Jun; 17(3):266-7. PubMed ID: 7542810
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus (FK 506): a whole blood assay as measured on the Abbott IMx analyzer.
McKenna BA; Pabico RC; Bronsther OL; Morris MC; Orloff MS; Erturk E
Transplant Proc; 1996 Apr; 28(2):988-90. PubMed ID: 8623491
[No Abstract] [Full Text] [Related]
18. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
[TBL] [Abstract][Full Text] [Related]
19. Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.
Lemster B; Huang LL; Irish W; Woo J; Carroll PB; Abu-Elmagd K; Rilo HR; Johnson N; Russell-Hall R; Fung JJ
Autoimmunity; 1994; 19(2):89-98. PubMed ID: 7539635
[TBL] [Abstract][Full Text] [Related]
20. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
